Agilent Technologies, Inc.

Equities

A

US00846U1016

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:30 28/06/2024 BST			5-day change	1st Jan Change
129.6 ^USD	-0.89%		-2.72%	-6.76%

06-27	Wolfe Research Downgrades Agilent Technologies to Peer Perform From Outperform	MT
06-27	RareCyte, Inc. announced that it has received $20 million in funding from a group of investors	CI

RareCyte, Inc. announced that it has received $20 million in funding from a group of investors

June 26, 2024

RareCyte, Inc. announced that it has received $20 million in a round of funding co-led by new investor Forest Road Company, LLC and returning investors Arboretum Ventures LLC, Impresa Management LLC on June 27, 2024. The transaction included participation from returning investors Gkcc, LLC, Sheatree Capital, Forest Road Company, LLC, Agilent Technologies, 5AM Venture Management, LLC, HealthQuest Capital and individual investors Ron Seubert.

Latest news about Agilent Technologies, Inc.

Wolfe Research Downgrades Agilent Technologies to Peer Perform From Outperform	06-27	MT
RareCyte, Inc. announced that it has received $20 million in funding from a group of investors	06-26	CI
Masimo Shareholder Politan Capital Campaigns for 2 More Board Seats	06-26	MT
Bristol Myers: ex-CEO of Agilent joins Board of Directors	06-19	CF
MGI Tech Co., Ltd. and SeqOne Partner to Advance End-To-End Genomic Analysis	06-17	CI
Agilent Technologies Insider Sold Shares Worth $1,999,262, According to a Recent SEC Filing	06-12	MT
Agilent Technologies Insider Sold Shares Worth $254,540, According to a Recent SEC Filing	06-05	MT
Agilent Technologies Seeks M&A	06-05	CI
Transcript : Agilent Technologies, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 08:30 AM	06-05
Agilent Technologies, Inc. Is Introducing Two New Products At the 72Nd Asms Conference on Mass Spectrometry and Allied Topics	06-03	CI
Tranche Update on Agilent Technologies, Inc. (NYSE:A)'s Equity Buyback Plan announced on January 9, 2023.	06-03	CI
A new phase for the market	05-30
UBS Cuts Price Target on Agilent Technologies to $141 From $155, Keeps Neutral Rating	05-30	MT
Wolfe Research Adjusts Agilent Technologies' PT to $135 From $155	05-30	MT
Leerink Adjusts Price Target on Agilent Technologies to $135 From $150	05-30	MT
Stifel Adjusts Price Target on Agilent Technologies to $151 From $163	05-30	MT
JPMorgan Adjusts Price Target on Agilent Technologies to $155 From $165	05-30	MT
Bernstein Adjusts Price Target on Agilent Technologies to $125 From $130	05-30	MT
TD Cowen Adjusts Price Target on Agilent Technologies to $153 From $163	05-30	MT
Citigroup Adjusts Price Target on Agilent Technologies to $135 From $145	05-30	MT
Baird Adjusts Price Target on Agilent Technologies to $136 From $147	05-30	MT
Goldman Sachs Adjusts Price Target on Agilent Technologies to $145 From $165	05-30	MT
Evercore ISI Adjusts Price Target on Agilent Technologies to $126 From $145	05-30	MT
North American Morning Briefing : Equity Futures Struggle as Bond Yields Hold Highs	05-30	DJ
Agilent lowers full-year revenue forecast on slowing demand from its biotech clients	05-29	RE

Chart Agilent Technologies, Inc.

Duration

Period

More charts

Company Profile

Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (73.9%) and services (26.1%). Net sales are distributed geographically as follows: the United States (40%), China (34.3%) and other (25.7%).

Sector

Advanced Medical Equipment & Technology

Calendar

01/07/2024 - Détachement de

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Agilent Technologies, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

129.6 USD

Average target price

139.8 USD

Spread / Average Target

+7.88%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
AGILENT TECHNOLOGIES, INC.	-6.76%	37.82B
THERMO FISHER SCIENTIFIC	+4.18%	211B
DANAHER CORPORATION	+8.00%	185B
INTUITIVE SURGICAL, INC.	+31.86%	158B
BOSTON SCIENTIFIC CORPORATION	+33.21%	113B
SIEMENS HEALTHINEERS AG	+2.28%	64.32B
EDWARDS LIFESCIENCES CORPORATION	+21.14%	55.66B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+0.11%	48.41B
GE HEALTHCARE TECHNOLOGIES INC.	+0.78%	35.57B
RESMED, INC.	+11.28%	28.12B

Other Advanced Medical Equipment & Technology